RESÚMENES MARZO 2009

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

 (Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

GRATIS = Texto gratuito en algunos países de la región iberoamericana (algunos artículos requieren ir a la tabla de contenidos del número actual de la revista)

 

1! - Are Patients With Depression at Heightened Risk of Suicide as They Begin to Recover?

Vikrant Mittal, Walter A. Brown, and Edward Shorter

Psychiatr Serv 60:384-386, March 2009

3! - Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

Rudolf Uher, Wolfgang Maier, Joanna Hauser, Andrej Marusic, Christine Schmael, Ole Mors, Neven Henigsberg, Daniel Souery, Anna Placentino, Marcella Rietschel, Astrid Zobel, Monika Dmitrzak-Weglarz, Ana Petrovic, Lisbeth Jorgensen, Petra Kalember, Caterina MD Giovannini, Mara Barreto, Amanda Elkin, Sabine Landau, Anne Farmer, Katherine J. Aitchison, and Peter McGuffin

The British Journal of Psychiatry (2009) 194: 252-259

 

3 - Escitalopram prolonged fear induced by simulated public speaking and released hypothalamic-pituitary-adrenal axis activation

C Garcia-Leal, CM Del-Ben, FM Leal, FG Graeff, and FS Guimarães

Journal of Psychopharmacology. First published on February 27, 2009

4 - Superiority of escitalopram to paroxetine in the treatment of depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Siegfried Kasper, David S. Baldwin, Sara Larsson Lönn and Jean-Philippe Boulenger

European Neuropsychopharmacology. Volume 19, Issue 4, April 2009, Pages 229-237

 

3! - Alprazolam treatment immediately after stress exposure interferes with the normal HPA-stress response and increases vulnerability to subsequent stress in an animal model of PTSD




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael A. Matar, Joseph Zohar, Zeev Kaplan and Hagit Cohen

European Neuropsychopharmacology. Volume 19, Issue 4, April 2009, Pages 283-295

 

5< - Effect of quetiapine vs. placebo on response to two virtual public speaking exposures in individuals with social phobia




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Christopher B. Donahue, Matt G. Kushner, Paul D. Thuras, Tom G. Murphy, Joani B. Van Demark and David E. Adson

Journal of Anxiety Disorders. Volume 23, Issue 3, April 2009, Pages 362-368

 

3! - A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression

Paul B. Fitzgerald, Kate Hoy, Zafiris J. Daskalakis, Jayashri Kulkarni

Depression and Anxiety. Volume 26 Issue 3, Pages 229 - 234

 

3 - Effect of medication and psychotherapy on heart rate variability in panic disorder

Amir Garakani, Jose M. Martinez, Cindy J. Aaronson, Andrei Voustianiouk, Horacio Kaufmann, Jack M. Gorman

Depression and Anxiety. Volume 26 Issue 3, Pages 251 - 258

 

3 - High worry severity is associated with poorer acute and maintenance efficacy of antidepressants in late-life depression

Carmen Andreescu, Eric J. Lenze, Benoit H. Mulsant, Julie Loebach Wetherell, Amy E. Begley, Sati Mazumdar, Charles F. Reynolds III

Depression and Anxiety. Volume 26 Issue 3, Pages 266 - 272

 

5 - Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis

Pim Cuijpers, Annemieke van Straten, Lisanne Warmerdam, Gerhard A

Depression and Anxiety. Volume 26 Issue 3, Pages 279 - 288

 

3 - Practice Guideline for the Treatment of Patients With Panic Disorder, Second Edition
APA Guideline 2009

 

3! - Selective Serotonin Reuptake Inhibitor Use and Risk of Gestational Hypertension

Sengwee Toh, Allen A. Mitchell, Carol Louik, Martha M. Werler, Christina D. Chambers, and Sonia Hernández-Díaz

Am J Psychiatry 2009; 166:320-328

3< - Effects of fluoxetine on fine motor performance in dysthymia: An 8-week, nonrandomized, open-label study




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Didier Schrijvers, Yvonne J. Maas and Bernard G.C. Sabbe

Clinical Therapeutics. Volume 31, Issue 1, January 2009, Pages 123-129

 

3 - Hemispheric Asymmetry in Resting Motor Threshold in Major Depression

Navarro, Rita; Zarkowski, Paul; Sporn, Alexandra; Avery, David

The Journal of ECT:Volume 25(1)March 2009pp 39-43

 

3 - Repetitive Transcranial Magnetic Stimulation for Treatment of Medication-Resistant Depression in Older Adults: A Case Series

Milev, Roumen; Abraham, Gaby; Hasey, Gary; Cabaj, Jason Lee

The Journal of ECT:Volume 25(1)March 2009pp 44-49

 

3 - The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Michael Kellner, Christoph Muhtz, Cüneyt Demiralay, Jana Husemann, Wiebke Koelsch, Alexander Yassouridis and Klaus Wiedemann

Journal of Psychiatric Research. Volume 43, Issue 6, March 2009, Pages 642-648

 

3 - Adjunctive glycine in the treatment of obsessive-compulsive disorder in adults




References and further reading may be available for this article. To view references and further reading you must purchase this article.

William M. Greenberg, Melissa M. Benedict, Joanna Doerfer, Megan Perrin, Laura Panek, W. Louis Cleveland and Daniel C. Javitt

Journal of Psychiatric Research. Volume 43, Issue 6, March 2009, Pages 664-670

 

3! - Outcome of late-life depression after 3 years of sequential treatment

R. M. Kok, W. A. Nolen, T. J. Heeren

Acta Psychiatrica Scandinavica. Volume 119 Issue 4, Pages 274 - 281

 

3! - Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder

R. H. Perlis, M. Fava, M. H. Trivedi, J. Alpert, J. F. Luther, S. R. Wisniewski, A. John Rush

Acta Psychiatrica Scandinavica. Volume 119 Issue 4, Pages 282 - 289

 

3 - How many well vs. unwell days can you expect over 10 years, once you become depressed?

T. A. Furukawa, R. Yoshimura, H. Harai, T. Imaizumi, H. Takeuchi, T. Kitamura, K. Takahashi

Acta Psychiatrica Scandinavica. Volume 119 Issue 4, Pages 290 - 297

 

5 - Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity

Original Paper

Differential effects of venlafaxine in the treatment of major depressive disorder according to baseline severity

Andreas B. Schmitt, Michael Bauer, Hans-Peter Volz, Hans-Jürgen Moeller, Qin Jiang, Philip T. Ninan and Peter-Andreas Loeschmann

European Archives of Psychiatry and Clinical Neuroscience. On Line First. March 2009

 

3 - Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study

Anita Rakic Ignjatovic, Branislava Miljkovic, Dejan Todorovic, Ivana Timotijevic & Milena Pokraja

British Journal of Clinical Pharmacology. Volume 67 Issue 2, Pages 199 - 208

 

3 - Involvement of serotoninergic 5-HT1A/2A, alpha-adrenergic and dopaminergic D1 receptors in St. John's wort-induced prepulse inhibition deficit: A possible role of hyperforin




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Mariane G. Tadros, Mohamed R. Mohamed, Amal M. Youssef, Gilane M. Sabry, Nagwa A. Sabry and Amani E. Khalifa

Behavioural Brain Research. Volume 199, Issue 2, 16 May 2009, Pages 334-339

 

3 - Lithium Therapy and Hyperparathyroidism: An Evidence-Based Assessment

Lithium Therapy and Hyperparathyroidism: An Evidence-Based Assessment

Brian D. Saunders, Erika F. H. Saunders and Paul G. Gauger

World Journal of Surgery. On Line First. February 2009

 

3 - Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use

A. G. Herzog, A. S. Blum, E. L. Farina, X. E. Maestri, J. Newman, E. Garcia, K. B. Krishnamurthy, D. B. Hoch, S. Replansky, K. M. Fowler, S. D. Smithson, B. A. Dworetzky, and E. B. Bromfield

NEUROLOGY 2009;72:911-914

3! - Can antiepileptic drugs unmask a susceptibility to psychiatric disorders?

Andres M Kanner

Nature Clinical Practice Neurology (2009) 5, 132-133

3! - Therapeutic Drug Monitoring of Lithium in Patients With Bipolar Affective Disorder: Experiences From a Tertiary Care Hospital in India
Sharma S, Joshi S, Chadda RK

Am J Ther. 2009 Feb 28. [Epub ahead of print]

 

3! - Effect of Exposure to Selective Serotonin Reuptake Inhibitors In Utero on Fetal Growth: Potential Role for the IGF-I and HPA Axes

DAVIDSON, SHMUEL; PROKONOV, DIANA; TALER, MICHAL; MAAYAN, RACHEL; HARELL, DANIELLA; GIL-AD, IRIT; WEIZMAN, ABRAHAM

Pediatric Research:Volume 65(2)February 2009pp 236-241

 

3! - Antidepressants that inhibit neuronal norepinephrine reuptake are not associated with increased spontaneous reporting of cardiomyopathy

S Ratcliffe, M Younus, M Hauben, and L Reich

J Psychopharmacol. First published on February 24, 2009

3! - Effects of adjunctive reboxetine in patients with duloxetine-resistant depression: a 12-week prospective study

J Seguí, F López-Muñoz, C Álamo, X Camarasa, P García-García, and A Pardo

Journal of Psychopharmacology. First published on March 12, 2009

3! - Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response

Wolfgang Block, Frank Träber, Olrik von Widdern, Martin Metten, Hans Schild, Wolfgang Maier, Astrid Zobel and Frank Jessen

The International Journal of Neuropsychopharmacology (2009), 12:415-422

 

3! - Stressful Life Events, Chronic Difficulties, and the Symptoms of Clinical Depression

Muscatell, Keely A; Slavich, George M; Monroe, Scott M; Gotlib, Ian H

The Journal of Nervous and Mental Disease:Volume 197(3)March 2009pp 154-160

 

3! - Association between antipsychotic combination therapy and treatment adherence among individuals with bipolar disorder

Frank D. Gianfrancesco, Martha Sajatovic, Eskinder TafesseRuey-Hua Wang

ANNALS OF CLINICAL PSYCHIATRY 2009;21(1):3–16

 

3! - Mood stabilizers and teratogenicity-prescribing practice and awareness amongst practising psychiatrists

Laraine James;  Carol Paton;  Paul Lelliott;  Thomas R. E. Barnes; David Taylor

Journal of Mental Health, Volume 18, Issue 2 April 2009, pages 137 - 143

 

3 - Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): A pilot study in drug resistant depressed patients




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Brisa Fernandes, Clarissa S. Gama, Rafael Massuda, Mariana Torres, Daniel Camargo, Mauricio Kunz, Paulo Silva Belmonte-de-Abreu, Flávio Kapczinski, Marcelo Pio de Almeida Fleck and Maria Inês Lobato

Neuroscience Letters. Volume 453, Issue 3, 10 April 2009, Pages 195-198

 

3! - A Randomized Trial of rTMS Targeted with MRI Based Neuro-Navigation in Treatment-Resistant Depression

Paul B Fitzgerald, Kate Hoy, Susan McQueen, Jerome J Maller, Sally Herring, Rebecca Segrave, Michael Bailey, Greg Been, Jayashri Kulkarni and ZafirisDaskalakis

Neuropsychopharmacology (2009) 34, 1255–1262

 

3 - Requirement of AQP4 for Antidepressive Efficiency of Fluoxetine: Implication in Adult Hippocampal Neurogenesis

Hui Kong, Luo-lin Sha, Yi Fan, Ming Xiao, Jian-hua Ding, Jie Wu and Gang Hu

Neuropsychopharmacology (2009) 34, 1263–1276

 

3! - Selective Serotonin Reuptake Inhibitor Exposure During Early Pregnancy and the Risk of Fetal Major Malformations: Focus on Paroxetine

Salvatore Gentile, and Cesario Bellantuono

J Clin Psychiatry 2009;70(3):414-422

 

5 - Evidence for Efficacy and Tolerability of Vilazodone in the Treatment of Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

Karl Rickels, Maria Athanasiou, Donald S. Robinson, Michael Gibertini, Heidi Whalen, and Carol R. Reed

J Clin Psychiatry 2009;70(3):326-333

 

3! - Early Improvement in the First 2 Weeks as a Predictor of Treatment Outcome in Patients With Major Depressive Disorder: A Meta-Analysis Including 6562 Patients

Armin Szegedi, Wim T. Jansen; Arjen P. P. van Willigenburg, Egbert van der Meulen, Hans H. Stassen, and Michael E. Thase

J Clin Psychiatry 2009;70(3):344-353

 

4 - Patient Preference as a Moderator of Outcome for Chronic Forms of Major Depressive Disorder Treated With Nefazodone, Cognitive Behavioral Analysis System of Psychotherapy, or Their Combination

James H. Kocsis, Andrew C. Leon, John C. Markowitz, Rachel Manber, Bruce Arnow, Daniel N. Klein, and Michael E. Thase

J Clin Psychiatry 2009;70(3):354-361

 

3 - Mirtazapine, a Sedating Antidepressant, and Improved Driving Safety in Patients With Major Depressive Disorder: A Prospective, Randomized Trial of 28 Patients

Jianhua Shen, Henry J. Moller, Xuehua Wang, Sharon A. Chung, Gilla K. Shapiro; Xiuying Li, and Colin M. Shapiro

J Clin Psychiatry 2009;70(3):370-377

 

4 - An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression

Madhukar H. Trivedi, Michael E. Thase, Olawale Osuntokun, David B. Henley, Michael Case, Susan B. Watson, Giedra M. Campbell, and Sara A. Corya

J Clin Psychiatry 2009;70(3):387-396

 

5 - Sexual Function in Postpartum Women Treated for Depression: Results From a Randomized Trial of Nortriptyline Versus Sertraline

Teresa Lanza di Scalea, Barbara H. Hanusa, and Katherine L. Wisner

J Clin Psychiatry 2009;70(3):423-428

 

GRATIS 3 - Desvenlafaxine in the treatment of major depressive disorder

Maria Teresa C Lourenco, Sidney H Kennedy

Neuropsychiatric Disease and Treatment. February 2009

 

GRATIS 3! - Association of PDE11A global haplotype with major depression and antidepressant drug response

Huai-Rong Luo, Gui-Sheng Wu, Chuanhui Dong, Mauricio Arcos-Burgos, Luciana Ribeiro, Julio Licinio, Ma-Li Wong

Neuropsychiatric Disease and Treatment. March 2009

 

3! - Major Depression and Antidepressant Treatment: Impact on Pregnancy and Neonatal Outcomes

Katherine L. Wisner, Dorothy K.Y. Sit, Barbara H. Hanusa, Eydie L. Moses-Kolko, Debra L. Bogen, Diane F. Hunker, James M. Perel, Sonya Jones-Ivy, Lisa M. Bodnar, and Lynn T. Singer

Am J Psychiatry Published March 16, 2009

5 - Maintenance Treatment for Patients With Bipolar I Disorder: Results From a North American Study of Quetiapine in Combination With Lithium or Divalproex (Trial 127)

Trisha Suppes, Eduard Vieta, Sherry Liu, Martin Brecher, Björn Paulsson, and Trial 127 Investigators

Am J Psychiatry Published March 16, 2009

5 - Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features

Sheehan, David V.; Nemeroff, Charles B.; Thase, Michael E.; Entsuah, Richard

International Clinical Psychopharmacology: March 2009 - Volume 24 - Issue 2 - pp 61-86

 

5 - Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial

Baldinetti, Francesca; Bandelow, Borwin; Kasper, Siegfried; Herman, Barry; Nivoli, Giancarlo; Ameringen, Michael Van; Petralia, Antonino; Mandel, Francine S

International Clinical Psychopharmacology: March 2009 - Volume 24 - Issue 2 - pp 87-96

 

3! - Feasibility of a slower lamotrigine titration schedule for bipolar depression: a naturalistic study

Joe, Soo Hyun; Chang, Jae Seung; Won, Seunghee; Rim, Hyo-Deog; Ha, Tae Hyon; Ha, Kyooseob

International Clinical Psychopharmacology: March 2009 - Volume 24 - Issue 2 - pp 105-110

 

3 - SLC6A4 variation and citalopram response

D.A. Mrazek, A.J. Rush, J.M. Biernacka, D.J. O'Kane, J.M. Cunningham, E.D. Wieben, D.J. Schaid, M.S. Drews, V.L. Courson, K.A. Snyder, J.L. Black III, R.M. Weinshilboum

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. Volume 150B Issue 3, Pages 341 - 351

 

GRATIS 5 - Placebo Response of Non-Pharmacological and Pharmacological Trials in Major Depression: A Systematic Review and Meta-Analysis

Brunoni AR, Lopes M, Kaptchuk TJ, Fregni F

PLoS ONE 2009; 4(3): e4824

 

3 - Recognition and treatment of depression in primary care: Effect of patients' presentation and frequency of consultation




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marco Menchetti, Martino Belvederi Murri, Klea Bertakis, Biancamaria Bortolotti and Domenico Berardi

Journal of Psychosomatic Research. Volume 66, Issue 4, April 2009, Pages 335-341

 

3! - Confusion, a Rather Serious Adverse Drug Reaction with Valproic Acid: A Review of the French Pharmacovigilance Database

E. Bondon-Guitton, A. Sommet, J. L. Montastruc and the French Association of Regional Pharmacovigilance Centres

Pharmacopsychiatry 2009; 42: 61-65

3! - Is Family History of Depression a Risk Factor for Poststroke Depression? Meta-Analysis

Tenev, Veselin T; Robinson, Robert G; Jorge, Ricardo E

American Journal of Geriatric Psychiatry: April 2009 - Volume 17 - Issue 4 - pp 276-280

 

3 - Patterns of Mild Cognitive Impairment After Treatment of Depression in the Elderly

Bhalla, Rishi K; Butters, Meryl A; Becker, James T; Houck, Patricia R; Snitz, Beth E; Lopez, Oscar L; Aizenstein, Howard J; Raina, Ketki D; DeKosky, Steven T; Reynolds, Charles F III

American Journal of Geriatric Psychiatry: April 2009 - Volume 17 - Issue 4 - pp 308-316

 

3! - Antidepressant medication use and breast cancer risk

Karen J. Wernli, John M. Hampton, Amy Trentham-Dietz, Polly A. Newcomb

Pharmacoepidemiology and Drug Safety. 2009; Volume 18 Issue 4, Pages 284 - 290

 

3! - Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Marianna Mazza, Laura Mandelli, Marco Di Nicola, Desiree Harnic, Valeria Catalano, Daniela Tedeschi, Giovanni Martinotti, Roberto Colombo, Pietro Bria, Alessandro Serretti and Luigi Janiri

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 27-35

 

3! - Long-term depression versus episodic major depression: Results from the prospective Zurich study of a community sample




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jules Angst, Alex Gamma, Wulf Rössler, Vladeta Ajdacic and Daniel N. Klein

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 112-121

 

3 - Adherence to continuation and maintenance antidepressant use in recurrent depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Mascha C. ten Doesschate, Claudi L.H. Bockting and Aart H. Schene

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 167-170

 

2! - Long term augmentation with T3 in refractory major depression




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Tammas F. Kelly and Daniel Z. Lieberman

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 230-233

 

3! - Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Jay D. Amsterdam and Justine Shults

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 234-240

 

2 - Lamotrigine in bipolar disorder: Results of a mirror-image evaluation using the NIMH Lifechart-Methodology




References and further reading may be available for this article. To view references and further reading you must purchase this article.

C. Born, B. Bernhard, S. Dittmann, F. Seemüller and H. Grunze

Journal of Affective Disorders. Volume 115, Issues 1-2, May 2009, Pages 241-245

 

3! - Depression and Clinical Outcomes in Heart Failure: An OPTIMIZE-HF Analysis




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Nancy M. Albert, Gregg C. Fonarow, William T. Abraham, Mihai Gheorghiade, Barry H. Greenberg, Eduardo Nunez, Christopher M. O'Connor, Wendy G. Stough, Clyde W. Yancy and James B. Young

The American Journal of Medicine. Volume 122, Issue 4, April 2009, Pages 366-373

 

3 - A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Mehdi Ghasemi, Hamed Sadeghipour, Gholamreza Poorheidari and Ahmad Reza Dehpour

Behavioural Brain Research. Volume 200, Issue 1, 8 June 2009, Pages 76-82

 

3 - Lithium: Updated Human Knowledge Using an Evidence-Based Approach: Part I: Clinical Efficacy in Bipolar Disorder

Grandjean, Etienne Marc; Aubry, Jean-Michel

CNS Drugs:Volume 23(3)2009pp 225-240

 

3! - Omega-3 deficiency associated with perinatal depression: Case control study




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Anne-Marie Rees, Marie-Paule Austin, Catherine Owen and Gordon Parker

Psychiatry Research. Volume 166, Issues 2-3, 30 April 2009, Pages 254-259

 

3 - Substance use disorders in an obsessive compulsive disorder clinical sample




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Maria C. Mancebo, Jon E. Grant, Anthony Pinto, Jane L. Eisen and Steven A. Rasmussen

Journal of Anxiety Disorders. Volume 23, Issue 4, May 2009, Pages 429-435

 

3 - Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Patrícia S. Brocardo, Josiane Budni, Kelly R. Lobato, Adair Roberto S. Santos and Ana Lúcia S. Rodrigues

Behavioural Brain Research. Volume 200, Issue 1, 8 June 2009, Pages 122-127

 

3 - Augmentation of antidepressants with perospirone for treatment-resistant major depressive disorder




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yasushi Sato, Norio Yasui-Furukori, Taku Nakagami, Manabu Saito and Sunao Kaneko

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 3, 30 April 2009, Pages 416-418

 

3! - Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Yu-Cheng Li, Fu-Meng Wang, Ying Pan, Li-Qin Qiang, Guang Cheng, Wei-Yun Zhang and Ling-Dong Kong

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 3, 30 April 2009, Pages 435-449

 

3! - Prediction of relapse in melancholic depressive patients in a 2-year follow-up study with corticotropin releasing factor test




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Luis Pintor, Xavier Torres, Victor Navarro, Ma Jesús Martinez de Osaba, Silvia Matrai and Cristobal Gastó

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 3, 30 April 2009, Pages 463-469

 

 

3 - Ascorbic acid administration produces an antidepressant-like effect: Evidence for the involvement of monoaminergic neurotransmission




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Ricardo W. Binfaré, Angelo O. Rosa, Kelly R. Lobato, Adair R.S. Santos and Ana Lúcia S. Rodrigues

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 33, Issue 3, 30 April 2009, Pages 530-540

 

5 - Duloxetine in acute major depression: review of comparisons to placebo and standard antidepressants using dissimilar methods

Paolo Girardi, Maurizio Pompili, Marco Innamorati, Michele Mancini, Gianluca Serafini, Lorenzo Mazzarini, Antonio Del Casale, Roberto Tatarelli, Ross J. Baldessarini

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 177 - 190

 

3 - Clonazepam as a therapeutic adjunct to improve the management of depression: a brief review

Shigeru Morishita

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 191 - 198

 

3! - The association of serotonin transporter genotypes and selective serotonin reuptake inhibitor (SSRI)-associated sexual side effects: possible relationship to oral contraceptives

Jeffrey R. Bishop, Vicki L. Ellingrod, Michael Akroush, Jessica Moline

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 207 - 215

 

3! - Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?

Gerard Clarke, Siobhain M O'Mahony, John F Cryan, Timothy G Dinan

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 3, Pages 217 - 223

 

5 - Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol – A double-blind multicenter trial




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Heike E. Künzel, Nibal Ackl, Martin Hatzinger, Katja Held, Edith Holsboer-Trachsler, Marcus Ising, Wolfgang Kaschka, Siegfried Kasper, Anastasios Konstantinidis, Annette Sonntag, Manfred Uhr, Alexander Yassouridis, Florian Holsboer and Axel Steiger

Journal of Psychiatric Research. Volume 43, Issue 7, April 2009, Pages 702-710

 

3! - Repeated electroconvulsive seizures increase the total number of synapses in adult male rat hippocampus




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Fenghua Chen, Torsten M. Madsen, Gregers Wegener and Jens R. Nyengaard

European Neuropsychopharmacology. Volume 19, Issue 5, May 2009, Pages 329-338

 

3! - Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Armando Piccinni, Alessandro Del Debbio, Pierpaolo Medda, Carolina Bianchi, Isabella Roncaglia, Antonello Veltri, Sara Zanello, Enrico Massimetti, Nicola Origlia, Luciano Domenici, Donatella Marazziti and Liliana Dell'Osso

European Neuropsychopharmacology. Volume 19, Issue 5, May 2009, Pages 349-355

 

3! - MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs




References and further reading may be available for this article. To view references and further reading you must purchase this article.

Johanna Hilli, Tuija Heikkinen, Riikka Rontu, Terho Lehtimäki, Ikuko Kishida, Eleni Aklillu, Leif Bertilsson, Tero Vahlberg and Kari Laine

European Neuropsychopharmacology. Volume 19, Issue 5, May 2009, Pages 363-370

 

3! - Prevalence and impact of antidepressant-associated sexual dysfunction in three European countries: replication in a cross-sectional patient survey

VSL Williams, HM Edin, SL Hogue, SE Fehnel, and DS Baldwin

Journal of Psychopharmacology First published on March 27, 2009

3 - Cytisine-Based Nicotinic Partial Agonists as Novel Antidepressant Compounds

Yann S. Mineur, Christoph Eibl, Grace Young, Christopher Kochevar, Roger L. Papke, Daniela Gündisch, and Marina R. Picciotto

JPET 329:377-386, 2009

 

3! - Lithium, Antipsychotics, and Risk of Psoriasis

Brauchli, Yolanda B; Jick, Susan S; Curtin, François; Meier, Christoph R

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 134-140

 

5< - Effects of Escitalopram on Anxiety and Respiratory Responses to Carbon Dioxide Inhalation in Subjects at High Risk for Panic Disorder: A Placebo-Controlled, Crossover Study

Coryell, William; Rickels, Heather

Journal of Clinical Psychopharmacology: April 2009 - Volume 29 - Issue 2 - pp 174-178

 

GRATIS 3 - Post-Traumatic Stress Disorder

Society for Neuroscience

Brain Briefings. March 2009

 

GRATIS 3! - Patient-Assessed Versus Physician-Assessed Disease Severity and Outcome in Patients With Nonspecific Pain Associated With Major Depressive Disorder

Koen Demyttenaere, Durisala Desaiah, Claude Petit, Jens Croenlein, and Stephan Brecht

Prim Care Companion J Clin Psychiatry. 2009; 11(1): 8–15

 

GRATIS 3 - Treatment-Resistant Depression - Part I: Introduction and Clinical Presentations

John P. O’Reardon
Psychiatry Weekly, March 23, 2009

 

GRATIS 3 - Treatment-Resistant Depression - Part II: Augmentation Strategies

Michael E. Thase
Psychiatry Weekly, March 30, 2009

 

GRATIS 3 - Are panic attacks really harmless? The cardiovascular impact of panic disorder

Aline Sardinha, Antonio Egidio Nardi, Walter Araújo Zin

Rev Bras Psiquiatr. 2009;31(1):57-62

.

Regresar a RESÚMENES MARZO 2009

.

© 1999-2009 Jorge M Tamayo, MD, BMSS

Creada en Enero 1999

Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA.